Specialty Pharma
Specialty pharma companies focus on cost-competitive supply or niche formulation and complex / hospital-only medicines.
Identifying Growth and Value in Specialty Pharma
Specialty pharma offers higher-margin opportunities, but relies on careful positioning of niche formulations, targeted commercial models, and clear differentiation in crowded therapeutic areas.
We help investors and management teams assess opportunities with precision. Our experience spans commercial due diligence, transaction and licensing support, and portfolio strategy. We analyse market dynamics, competitor positioning, and product-level economics to determine where growth prospects are credible and where risks may be understated.
We have exceptional experience in rare disease speciality pharma, having advised many investors in this sub-field over many years.
Our specialty pharma leads
Our teams benchmark valuations against relevant deal activity, review R&D and pipeline sustainability, and assess regulatory and pricing environments across regions. This provides clients with a clear view of realistic market potential, informed by both scientific and commercial perspectives.
Beyond individual transactions, we support strategy development by examining market entry options, growth strategies, and partnership opportunities. By combining rigorous analysis with practical insight, we enable generics and specialty pharma companies — and their investors — to make sound strategic choices and capture long-term value.
News & Insights
